Target intelligence / Profile preview

Cathepsin L pseudogene

Molecular classification
Other (Pseudogene), Not a functional enzyme, transporter, or receptor
01

Overview

Cathepsin L pseudogene (ENSG00000234460) is a genomic DNA sequence resembling the cathepsin L gene but is classified as a pseudogene, meaning it is transcriptionally inactive and does not encode a functional protein product. Cathepsin L itself is an important cysteine protease involved in lysosomal protein degradation, antigen presentation, and other cellular processes, and dysregulated cathepsin L activity has been implicated in diseases including cancer and viral entry. However, the pseudogene variant contains disabling mutations or lacks regulatory features essential for functional expression. There is no evidence that this pseudogene is a therapeutic target or has direct biological or clinical relevance. Additional Context: - Functional cathepsin L (CTSL) is a classical cysteine protease in the endopeptidase family, but the pseudogene does not function in this capacity. - Pseudogenes, such as "cathepsin L pseudogene," often arise from gene duplication or retrotransposition events and generally do not have functional protein products, though in rare cases some may regulate related genes via non-coding RNA roles—no such functions are established for ENSG00000234460. - Drug discovery efforts focus on the protein-coding "cathepsin L" (gene symbol CTSL or CTSL1 in humans), not on pseudogenes. If structured information is required for a true therapeutic target, refer to the functional protein "cathepsin L" or "cathepsin L1" (gene: CTSL, Ensembl: ENSG00000135047), not the pseudogene.

Other names
CTSL pseudogeneCTSLPcathepsin L pseudogene
02

Biological functions

Other (Pseudogenes may have regulatory RNA roles but do not encode protein product; no well-characterized functions are established for this pseudogene)
03

Disease associations

Other (No direct disease association for this specific pseudogene; functional cathepsin L is involved in multiple diseases but not the pseudogene itself)

Beyond the preview

Go deeper on Cathepsin L pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cathepsin L pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call